TY - JOUR
T1 - Inhibitory receptors, ITIM sequences and phosphatases
AU - Unkeless, Jay C.
AU - Jin, Jie
N1 - Funding Information:
This work was supported in part by National Institutes of Health grants AI-24322 and A1-24671.
PY - 1997/6
Y1 - 1997/6
N2 - A diverse group of inhibitory receptors, including FcγRII, killer cell inhibitory receptors, and B22, shares an immunoreceptor tyrosine-based inhibition motif (ITIM). Recent studies have shown that this motif, when phosphorylated on tyrosine, forms a docking site for the Src homology 2 recognition domains of the protein tyrosine phosphatase SHP-1 and the inositol 5-phosphatase SHIP. A similar motif in cytotoxic T-lymphocyte antigen-4 recruits the related tyrosine phosphatase SHP-2. These three enzymes act to inhibit signaling cascades resulting from ligation of the BCR, TCR, FcγRIII, and FcεRI, although the relative importance of the tyrosine phosphatases and the inositol phosphatase differs depending on the cell type.
AB - A diverse group of inhibitory receptors, including FcγRII, killer cell inhibitory receptors, and B22, shares an immunoreceptor tyrosine-based inhibition motif (ITIM). Recent studies have shown that this motif, when phosphorylated on tyrosine, forms a docking site for the Src homology 2 recognition domains of the protein tyrosine phosphatase SHP-1 and the inositol 5-phosphatase SHIP. A similar motif in cytotoxic T-lymphocyte antigen-4 recruits the related tyrosine phosphatase SHP-2. These three enzymes act to inhibit signaling cascades resulting from ligation of the BCR, TCR, FcγRIII, and FcεRI, although the relative importance of the tyrosine phosphatases and the inositol phosphatase differs depending on the cell type.
UR - http://www.scopus.com/inward/record.url?scp=0030873248&partnerID=8YFLogxK
U2 - 10.1016/S0952-7915(97)80079-9
DO - 10.1016/S0952-7915(97)80079-9
M3 - Article
C2 - 9203414
AN - SCOPUS:0030873248
SN - 0952-7915
VL - 9
SP - 338
EP - 343
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
IS - 3
ER -